A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
Recent Abstracts
Trouble Brewing – The Case for Alcohol Policy (Second Edition)
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Clean Air in Jakarta: Gaps and Possibilities Toward Low Emission Practices
Public Attitudes Towards Alcohol Policy: South Africa
Quality Assurance and Improvement Framework for Medical Certification of Cause of Death and…
More Data Better Health: Climate and Health in the Legal Amazon
Mais Dados Mais Saúde: Clima e Saúde na Amazônia Legal
Health Taxes Action Guide
Opinión pública frente a la política de alcohol: Colombia